FindTrial
Sign In

Study for application of HOXA5-PTPRZ1 in the pathology classification of glioblastoma

Study for application of HOXA5-PTPRZ1 in the pathology classification of glioblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047913
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:none

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The clinical diagnosis was diffuse astrocytoma.

Exclusion criteria

Exclusion criteria: Cases with undetermined tumor grade.

Design outcomes

Primary

MeasureTime frame
Histological typing;The general shape of the specimen;Immunohistochemical indicators;—

Countries

China

Contacts

Public ContactPing Yifang
pingyifang@126.com+86 18623448461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026